The mechanism of action includes several key effects: Stimulating insulin secretion from the pancreas in a glucose-dependent manner, helping to control blood sugar levels Slowing gastric emptying , which prolongs the feeling of fullness after meals Reducing appetite through effects on brain centres that regulate hunger Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver By targeting these multiple pathways, GLP-1 medications can lead to significant weight loss when combined with lifestyle modifications
Tirzepatide second target: GIP receptors GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone released from the gut after eating
Extended Data Figure 2 GLP-1R interhelical interaction network
Its table also credits threads that mention initial blood work and ongoing monitoring, and that discuss gastrointestinal, injection-related or cardiovascular considerations honestly instead of downplaying them
SEE WHICH OPTION IS RIGHT FOR YOUR GOALS Can You Switch From Semaglutide to Retatrutide
The global GLP-1 receptor agonist market size is valued at USD 53.5 billion in 2024 and is expected to grow to USD 62.86 billion by 2025
